Listening To The Brain: How Adaptive DBS Is Restoring Stability And Hope In Parkinson’s Care - Dr. Akshat Kayal

Technology is fundamentally transforming how we manage chronic, progressive neurological conditions, replacing one-size-fits-all treatments with intelligent, responsive care. For people living with Parkinson’s disease, daily life is often defined by unpredictable fluctuations. Symptoms shift continuously as medication kicks in and wears off, creating uncertain windows of control that directly impact a person’s basic independence, dignity, and overall quality of life. Deep brain stimulation, or DBS, has long been an option for suitable patients, working by delivering electrical pulses to movement-related areas of the brain. What is changing now is that a new generation of DBS can sense what is happening in the brain and respond to it. At Kokilaben Dhirubhai Ambani Hospital, the DBS Programme has implanted 45 sensing-enabled directional DBS systems, programmed 30 patients in adaptive mode, and currently has around 20 patients receiving adaptive stimulation. This growing clinical experience reflects a larger movement in modern medicine, marking a shift toward brain stimulation that moves alongside the patient’s lived reality rather than remaining fixed.

In conventional DBS, settings remain static until the next clinic visit. Adaptive DBS introduces a dynamic feedback loop where the system continuously records selected electrical brain signals (local field potentials) and automatically adjusts stimulation within safe limits set by the clinical team. Think of a smart thermostat: it does not cool at a constant rate regardless of room temperature; it reads the environment and adjusts accordingly. Adaptive DBS works on the exact same principle. Crucially, it does not read thoughts, diagnose disease, or make autonomous treatment decisions. The clinical team remains entirely in control.

For patients, what this means in practice is that stimulation can respond to changes that happen between clinic visits rather than waiting until the next appointment. The aim is to reduce the periods where stimulation is either not enough or too much, and to use the device more efficiently as brain activity changes. That said, adaptive DBS is not a cure. It does not slow or stop the progression of Parkinson's disease, and how much benefit a patient experience will vary from person to person. Conventional DBS remains the right choice for many patients.

The surgical procedure itself is not fundamentally different. Patients going through DBS for the first time follow the same established assessment and implantation pathway. Adaptive therapy needs compatible sensing-enabled hardware and is switched on through programming after the clinical team has identified a useful signal and set the appropriate parameters. Some patients who already have compatible systems may be considered for adaptive programming without needing another brain operation.

The work does not stop at implantation. Patients go through structured programming sessions where symptoms, medication response, movement scores, involuntary movements, stimulation settings, and patient preferences are all reviewed carefully. Most patients need three or four programming visits before adaptive stimulation is started, followed by ongoing optimisation and follow-up over time.

Adaptive DBS represents the future of functional neurosurgery and modern neurological care. As medical technology learns to listen to the human body, care shifts away from rigid therapy toward intelligent systems that adapt to biological signals, offering millions living with Parkinson's disease a future of more personalized, responsive, and humane medicine.